Building Greater Supply-Chain Resiliency: What Are Leading Experts Saying?

Executives at DCAT Week’s education programs will address the industry’s most pressing challenges: inflationary pressures, supply-chain disruptions in a post-pandemic environment, and geopolitical and economic uncertainty. Hear from leading experts who will provide practical insights to address these challenges, including new tools/approaches to identify and mitigate supply risk.

Executives at DCAT Week’s education programs will address the industry’s most pressing challenges: inflationary pressures, supply-chain disruptions in a post-pandemic environment, and geopolitical and economic uncertainty. Hear from leading experts who will provide practical insights to address these challenges, including new tools/approaches to identify and mitigate supply risk. 

Changing customer-supplier expectations
How has the normal course of business between customers and suppliers changed in light of recent market volatility (inflationary pressures, supply-chain disruptions, and geopolitical uncertainty)?

Speaking at the DCAT Week Executive Insights program are (left to right): David Freidinger, Vice President, Business Management, Pharma Solutions, BASF Corporation; Wim Celen, Managing Director and Partner, Boston Consulting Group; Steve Kirk, Global Chief of Procurement, Catalent Pharma Solutions; Karin Shanahan, Executive Vice President, Global Product Development & Supply, Bristol-Myers Squibb

During DCAT Week, senior executives rom Bristol-Myers Squibb, Catalent, and BASF will share their perspectives on these recent changes. Executive Insights: Weathering the Storm – The Path Forward in Optimizing Supply Practices will address these all-important questions:

  • What are the new best practices and approaches in contracting? 
  • How has supplier evaluation and selection been affected?
  • What are the risk-mitigation strategies needed now and how can we anticipate the ones that will be necessary in the future? 

The program will be held at the InterContinental Barclay Hotel, Grand Ballroom on Tuesday, March 21, 2023: 10:30 – 11:45 AM; Doors open at 10:00 AM for coffee & networking.   

Register or learn more about the program here.  

Out-of-industry views
How are other industries dealing with the unprecedented supply-chain challenges of today?  The Disruption Busters: New Approaches in Supplier Risk Assessment & Mitigation, presented at DCAT Week, will provide expert insight from the automotive, tech, and other industries on new approaches/tools in supplier risk assessment and mitigation to build greater supply-chain resiliency. 

The program features executives from the management-consulting firm, Kearney (formerly A.T. Kearney) and the firms’ Center for Supplier Risk Management, and the Axia Institute, a research and education center of Michigan State University (MSU), with whom DCAT partnered with for this program. The Axia Institute was founded by leaders in value-chain creation and development at MSU, including the Broad College of Business, which is recognized for its top-ranked Supply Chain Management Program (U.S. News & World Report, 2022). DCAT is also a partner with MSU’s Broad College of Business and its top-ranked Supply Chain Management Program.  

The Disruption Busters: New Approaches in Supplier Risk Assessment & Mitigation  will be held at the InterContinental Barclay Hotel, Grand Ballroom on Wednesday, March 22, 2023: 10:15 AM – 11:30 AM. 

Register or learn more about this program here.     

A C-suite view on sustainability

Lisa Martin,
Senior Vice President, Global Procurement, and Chief Procurement Officer,
GlaxoSmithKline

Sustainability has become an all-important issue in bio/pharma companies’ selection and evaluation of their suppliers as companies seek to reduce their carbon footprint in line with international climate goals. But what are bio/pharma companies expecting from their suppliers, and how can suppliers meet those expectations?

GlaxoSmithKline’s (GSK) Chief Procurement Officer (CPO), Lisa Martin, will provide a C-suite view of sustainability at the DCAT Week education program, Industry Radar 2023: Energy, Raw Materials & Sustainability. She will discuss GSK’s sustainable procurement program for suppliers and how it is working with suppliers to meet the company’s environmental targets in emissions, water usage, and waste reduction. The program will provide practical insights on how your company can meet its sustainability targets in its sourcing and supply practices, and for suppliers, the program provides a customer-centric view on what it takes to be a valued partner in sustainability. 

The program will also examine another hot-button issue in 2023: rising input costs by providing an energy and chemicals outlook to see the pressure points in raw materials costs and what can be expected in 2023 and the near term. 

The program will be held at the InterContinental Barclay Hotel, Grand Ballroom on Tuesday, March 21, 2023: 2:00 PM – 3:15 PM; Doors open at 1:30 PM for coffee & networking.

Register or learn more about this program here

Recent Feature Articles

The US and the Bio/Pharma Supply Chain: What’s Next?

By
The President Joe Biden convened the inaugural meeting of the White House Council on Supply Chain Resilience to outline a plan to address supply-chain vulnerabilities and support domestic manufacturing, including for the bio/pharma industry.

The Year in Review: The Top 10 News Stories from 2023

By
As we begin to look back at 2023, what were the top news developments from this year from the bio/pharma industry and which impacted the industry? DCAT Value Chain Insights provides its Top 10 News Stories of 2023 in M&A, product innovation, and manufacturing.

The Innovation Leaders: Best Practices in Supply Management

By
A new program at DCAT Week 2024, Best Practices Platform: Industry Case Studies, will provide innovative approaches on how customers and suppliers are bringing supply management to the next level. Topics of interest include strategies in supplier risk management, ways to improve time to market, and other innovative approaches in sourcing and supply management. DCAT Member Companies can apply to present a case study. Applications close November 30, and presentations are due February 2024.

The Risks and Rewards: Tracking Investors’ Confidence

By
What do investors see as the most significant issues in assessing which companies offer the best financial opportunities? A new global study by the management-consulting firm, PwC, examines investors’ decision criteria in evaluating companies’ strengths and weaknesses in macroeconomic responsiveness, emerging technologies such as artificial intelligence, and sustainability. What do investors see as the key risks and rewards, and how would your company measure up in this assessment?